Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 2, 1998, Pages 197-200

  Baron, F ^a   Sadzot, B ^a   Wang, F ^a   Beguin, Y ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b FNRS   (Belgium)

Author keywords

Aplastic anemia; Bone marrow transplantation; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CYCLOSPORIN; HLA ANTIGEN; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CASE REPORT; DYSPHAGIA; ELECTROMYOGRAM; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031927234     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701297     Document Type: Article

References (15)

1. Smith CI, Aarli JA, Biberfeld P et al. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. New Engl J Med 1983; 309: 1565-1568.
2. Seely E, Drachman D, Smith BR et al. Post bone marrow transplantation (BMT) myasthenia gravis: evidence for acetyl- choline receptor (AChR) abnormality. Blood 1984; 64 (Suppl. 1): 221a.
3. Bolger GB, Sullivan KM, Spence AM et al. Myasthenia gravis after allogeneic hone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087-1091.
4. Lefvert AK, Bolme P, Hammarström L et al. Bone marrow grafting selectively induces the production of acetylcholine receptor antibodies, immunoglobulins bearing related idiotypes, and anti-idiotypic antibodies. Ann NY Acad Sci 1987; 505: 825-827.
5. Atkinson K, Bryant D, Delprado W, Biggs J. Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 129-132.
6. Grau JM, Casademont J, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990; 5: 435-137.
7. Abecassis MM. Complicaçoes pouco habituais da transplantacao de medula ossea (TMO). Experiência da Unidade de TMO do Institue Português de Oncologia de Francisco Gentil, Centro de Lisboa. Acta Med Portuguesa 1991; 4 (Suppl 1): 37-38.
8. Melms A, Faul C, Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992; 9: 78-79.
9. Haslam PJ, Proctor SJ, Goodship TH, Zouvani J. Immune complex glomerulonephritis. myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation. Nephrol Dial Transplant 1993; 8: 1390-1392.
10. Shimoda K, Gondo H, Harada M et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-156.
11. Zaja F, Russo D, Silvestri F et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 15: 649-650.
12. Adams C, August CS, Maguire H, Sladky JT. Neuromuscular complications of bone marrow transplantation. Pediat Neurol 1995; 12: 58-61.
13. Drachman DB. Myasthenia gravis. New Engl J Med 1994; 330: 1797-1810.
14. Smith CI, Hammarström L, Lefvert AK. Bone marrow grafting induces acelylcholine receptor antibody formation. Lancet 1985; i: 978.
15. Lefvert AK, Bjorkholm M. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting. New Engl J Med 1987; 317: 170.